Bragar Eagel & Squire, P.C. Launches Investigation into Agilon, Soleno, Avita, and Coty, Urging Investors to Reach Out to the Firm
Agilon Health Investigation: Bragar Eagel & Squire, P.C. is investigating Agilon Health for potential violations of federal securities laws following the unexpected resignation of its CEO and the withdrawal of its earnings guidance, which led to a significant drop in share price.
Soleno Therapeutics Report: The law firm is also looking into Soleno Therapeutics after a report from Scorpion Capital criticized its product, Vykat XR, as overpriced and unsafe, resulting in a notable decline in the company's stock price.
AVITA Medical Claims Backlog: AVITA Medical is under investigation due to a reported backlog of unpaid claims for its Recell procedures, which negatively impacted its financial results and led to a sharp decrease in share price.
Coty's Financial Losses: Coty, Inc. is facing scrutiny after reporting an unexpected financial loss and disappointing guidance, attributed to broader market challenges, which caused its stock price to fall significantly.
Get Free Real-Time Notifications for Any Stock
Analyst Views on AGL
About AGL
About the author

Agilon Health Faces Class Action Lawsuit Notification
- Class Action Initiation: Levi & Korsinsky LLP has notified investors that Agilon Health, Inc. (NYSE: AGL) is facing a class action lawsuit for alleged securities fraud, with the lawsuit covering the period from February 26, 2025, to August 4, 2025, aimed at recovering losses for affected investors.
- False Statement Allegations: The complaint alleges that the defendants recklessly issued guidance for 2025 despite being aware of significant industry headwinds, and materially overstated the positive financial impact of 'strategic actions' taken by Agilon, resulting in misleading statements about the company's business and prospects.
- Investor Rights Protection: Affected investors have until March 2, 2026, to apply to be appointed as lead plaintiff to share in any recovery, with no out-of-pocket costs or fees required to participate, thereby lowering the barrier for investor involvement in the lawsuit.
- Law Firm Background: Levi & Korsinsky has over 20 years of experience in securities litigation, having secured hundreds of millions for aggrieved shareholders, and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years, demonstrating its expertise in complex securities cases.

Faruqi & Faruqi Investigates Securities Fraud at agilon health
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud claims against agilon health, focusing on investor losses incurred between February 26 and August 4, 2025, indicating significant legal risks for the company.
- Financial Guidance Missteps: The lawsuit alleges that agilon health executives recklessly issued guidance for 2025 that they knew was unattainable due to known industry headwinds, resulting in substantial investor losses and highlighting governance failures within the company.
- Stock Price Plunge: Following the announcement to suspend its 2025 financial guidance, agilon health's stock plummeted by 51.5% on August 5, 2025, reflecting severe market concerns regarding the company's financial health.
- Investor Rights Protection: Faruq & Faruqi encourages investors to be aware that March 2 is the deadline to apply as lead plaintiff in the class action, emphasizing the importance of protecting investor rights.








